Research
Hormonal
Incretin-based therapies resulted in significant reductions in body weight and/or body mass index in patients with obstructive sleep apnea.
Practitioners may consider incretin-based therapies as effective options for weight management in OSA patients.
StrongSupportsmedium confidence
Collectively, the studies enrolled 1024 patients, lasted ≥12 weeks with liraglutide or tirzepatide, and resulted in significant reductions in body weight and/or body mass index.
Why this rating
Based on the systematic review and meta-analysis of randomized controlled trials.
Source
Efficacy of incretin-based therapies in obesity-related obstructive sleep apnea: a systematic review and meta-analysis of randomized controlled trials
Anna Bardóczi et al. · Sleep Medicine Reviews · 2025
Meta-analysisCited 12×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →